Cargando…

Maternal LINE-1 DNA Methylation and Congenital Heart Defects in Down Syndrome

Background: Down syndrome (DS) is one of the most common chromosomal abnormalities associated with congenital heart defects (CHD), with approximately 40 to 60% of cases showing cardiac defects. This study assessed (i) the association between maternal LINE-1 methylation and the occurrence of CHDs in...

Descripción completa

Detalles Bibliográficos
Autores principales: Babić Božović, Ivana, Stanković, Aleksandra, Živković, Maja, Vraneković, Jadranka, Mahulja-Stamenković, Vesna, Brajenović-Milić, Bojana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372553/
https://www.ncbi.nlm.nih.gov/pubmed/30787943
http://dx.doi.org/10.3389/fgene.2019.00041
_version_ 1783394766050820096
author Babić Božović, Ivana
Stanković, Aleksandra
Živković, Maja
Vraneković, Jadranka
Mahulja-Stamenković, Vesna
Brajenović-Milić, Bojana
author_facet Babić Božović, Ivana
Stanković, Aleksandra
Živković, Maja
Vraneković, Jadranka
Mahulja-Stamenković, Vesna
Brajenović-Milić, Bojana
author_sort Babić Božović, Ivana
collection PubMed
description Background: Down syndrome (DS) is one of the most common chromosomal abnormalities associated with congenital heart defects (CHD), with approximately 40 to 60% of cases showing cardiac defects. This study assessed (i) the association between maternal LINE-1 methylation and the occurrence of CHDs in children with DS and (ii) the impact of endogenous maternal factors (MTHFR C677T polymorphism and maternal age) and exogenous maternal factors (cigarette smoking, alcohol intake, medication use, body mass index and dietary habits such as folate intake) on maternal LINE-1 methylation and on the occurrence of CHD in children with DS. Patients and Methods: The study included 90 mothers of children with DS of maternal origin (49% DS-CHD(+) mothers/51% DS-CHD(−) mothers). LINE-1 DNA methylation was analyzed in peripheral blood lymphocytes by quantification of LINE-1 methylation using the MethyLight method. MTHFR C677T polymorphism genotyping was performed using PCR-RFLP. Results: LINE-1 methylation was not significantly different between DS-CHD(+) and DS-CHD(−) mothers (P = 0.997). Combination of MTHFR C677T genotype/diet and BMI were significant independent predictors of LINE-1 DNA methylation in DS-CHD(+) mothers (β −0.40, P = 0.01 and β −0.32, P = 0.03, respectively). In the analyzed multivariate model (model P = 0.028), these two factors explained around 72% of the variance in LINE-1 DNA methylation in mothers of children with DS and CHD. The group with the highest BMI (≥30 kg/m2) had significantly lower LINE-1 methylation than the group with normal BMI (Bonferroni post hoc P = 0.03) and the overweight group (Bonferroni post hoc P = 0.04). The lowest LINE-1 DNA methylation values were found in DS-CHD(+) mothers with the CT+TT genotype and a low-folate diet; the values were significantly lower than the values in mothers with the CC genotype and a folate-rich diet (Bonferroni post hoc P = 0.04). Conclusion: Association between maternal LINE-1 methylation and CHD in children with DS was not found. Study showed that the MTHFR genotype/diet combination and BMI were significantly associated with LINE-1 methylation in mothers of children with DS-CHD(+). These results highlight the need for a multifactorial approach to assess the roles of endogenous and exogenous maternal factors in maternal LINE-1 DNA methylation and the consequent pathologies in children. More extensive studies in a larger sample may help elucidate these relationships.
format Online
Article
Text
id pubmed-6372553
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63725532019-02-20 Maternal LINE-1 DNA Methylation and Congenital Heart Defects in Down Syndrome Babić Božović, Ivana Stanković, Aleksandra Živković, Maja Vraneković, Jadranka Mahulja-Stamenković, Vesna Brajenović-Milić, Bojana Front Genet Genetics Background: Down syndrome (DS) is one of the most common chromosomal abnormalities associated with congenital heart defects (CHD), with approximately 40 to 60% of cases showing cardiac defects. This study assessed (i) the association between maternal LINE-1 methylation and the occurrence of CHDs in children with DS and (ii) the impact of endogenous maternal factors (MTHFR C677T polymorphism and maternal age) and exogenous maternal factors (cigarette smoking, alcohol intake, medication use, body mass index and dietary habits such as folate intake) on maternal LINE-1 methylation and on the occurrence of CHD in children with DS. Patients and Methods: The study included 90 mothers of children with DS of maternal origin (49% DS-CHD(+) mothers/51% DS-CHD(−) mothers). LINE-1 DNA methylation was analyzed in peripheral blood lymphocytes by quantification of LINE-1 methylation using the MethyLight method. MTHFR C677T polymorphism genotyping was performed using PCR-RFLP. Results: LINE-1 methylation was not significantly different between DS-CHD(+) and DS-CHD(−) mothers (P = 0.997). Combination of MTHFR C677T genotype/diet and BMI were significant independent predictors of LINE-1 DNA methylation in DS-CHD(+) mothers (β −0.40, P = 0.01 and β −0.32, P = 0.03, respectively). In the analyzed multivariate model (model P = 0.028), these two factors explained around 72% of the variance in LINE-1 DNA methylation in mothers of children with DS and CHD. The group with the highest BMI (≥30 kg/m2) had significantly lower LINE-1 methylation than the group with normal BMI (Bonferroni post hoc P = 0.03) and the overweight group (Bonferroni post hoc P = 0.04). The lowest LINE-1 DNA methylation values were found in DS-CHD(+) mothers with the CT+TT genotype and a low-folate diet; the values were significantly lower than the values in mothers with the CC genotype and a folate-rich diet (Bonferroni post hoc P = 0.04). Conclusion: Association between maternal LINE-1 methylation and CHD in children with DS was not found. Study showed that the MTHFR genotype/diet combination and BMI were significantly associated with LINE-1 methylation in mothers of children with DS-CHD(+). These results highlight the need for a multifactorial approach to assess the roles of endogenous and exogenous maternal factors in maternal LINE-1 DNA methylation and the consequent pathologies in children. More extensive studies in a larger sample may help elucidate these relationships. Frontiers Media S.A. 2019-02-06 /pmc/articles/PMC6372553/ /pubmed/30787943 http://dx.doi.org/10.3389/fgene.2019.00041 Text en Copyright © 2019 Babić Božović, Stanković, Živković, Vraneković, Mahulja-Stamenković and Brajenović-Milić. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Babić Božović, Ivana
Stanković, Aleksandra
Živković, Maja
Vraneković, Jadranka
Mahulja-Stamenković, Vesna
Brajenović-Milić, Bojana
Maternal LINE-1 DNA Methylation and Congenital Heart Defects in Down Syndrome
title Maternal LINE-1 DNA Methylation and Congenital Heart Defects in Down Syndrome
title_full Maternal LINE-1 DNA Methylation and Congenital Heart Defects in Down Syndrome
title_fullStr Maternal LINE-1 DNA Methylation and Congenital Heart Defects in Down Syndrome
title_full_unstemmed Maternal LINE-1 DNA Methylation and Congenital Heart Defects in Down Syndrome
title_short Maternal LINE-1 DNA Methylation and Congenital Heart Defects in Down Syndrome
title_sort maternal line-1 dna methylation and congenital heart defects in down syndrome
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372553/
https://www.ncbi.nlm.nih.gov/pubmed/30787943
http://dx.doi.org/10.3389/fgene.2019.00041
work_keys_str_mv AT babicbozovicivana maternalline1dnamethylationandcongenitalheartdefectsindownsyndrome
AT stankovicaleksandra maternalline1dnamethylationandcongenitalheartdefectsindownsyndrome
AT zivkovicmaja maternalline1dnamethylationandcongenitalheartdefectsindownsyndrome
AT vranekovicjadranka maternalline1dnamethylationandcongenitalheartdefectsindownsyndrome
AT mahuljastamenkovicvesna maternalline1dnamethylationandcongenitalheartdefectsindownsyndrome
AT brajenovicmilicbojana maternalline1dnamethylationandcongenitalheartdefectsindownsyndrome